Phase II Sunitinib Prog Met AIPC

Clinical trial NCT00599313 · COMPLETED

Trial details

NCT number: NCT00599313
Sponsor: US Oncology Research
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Prostate Cancer

Start date: 2007-03-01
Primary completion: 2009-06-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.